Inhaled corticosteroids may increase diabetes riskDecember 15th, 2010 - 4:27 pm ICT by ANI
Washington, Dec 15 (ANI): Although inhaled corticosteriods are widely used for treating asthma and chronic obstructive pulmonary disorder (COPD), these drugs may be associated with diabetes development progression, says a study.
The researchers found that inhaled corticosteroids were associated with a 34 percent increase in the rate of diabetes onset and in the rate of diabetes progression.
At the highest inhaled doses the risk increased by 64 percent in diabetes onset and 54 percent in diabetes progression.
Since COPD and diabetes tend to increase with age, it is particularly important to assess any possible interaction between inhaled corticosteroid use and deterioration in glycemic control.
Investigators from McGill University and the Lady Davis Institute of the Jewish General Hospital, Montreal, Quebec, used data from over 380,000 patients treated for respiratory diseases identified in the Quebec health insurance databases.
30,167 patients developed diabetes during 5 and half years of follow-up and another 2099 who progressed from oral hypoglycemic treatment to insulin.
Lead investigator Samy Suissa of Lady Davis Research Institute observed that,” high doses of inhaled corticosteroids commonly used in patients with COPD are associated with an increase in the risk of requiring treatment for diabetes and of having to intensify therapy to include insulin.”
“Therefore, patients instituting therapy with high doses of inhaled corticosteroids should be assessed for possible hyperglycemia and treatment with high doses of inhaled corticosteroids limited to situations where the benefit is clear,” she added.
This large cohort allowed the accurate estimation of relative risk. There have been other major randomized trials that have not shown a significant association of inhaled corticosteroids and diabetes onset.
In this study, the authors found an incidence of diabetes onset of 14.2 per 1000 patients per year.
The study has been published in recent issue of The American Journal of Medicine. (ANI)
- Inhaled steroids up diabetes risk: Study - Nov 02, 2010
- Here come smart insulin pumps for diabetic kids - Apr 12, 2012
- Now, alternate therapy for adults with poorly controlled asthma - Sep 20, 2010
- Inhaled corticosteroid therapy helps reduce pneumonia mortality - Apr 16, 2011
- Type 2 diabetes, insulin use linked to colorectal cancer in men - Oct 19, 2010
- Insulin could play powerful role in fighting Alzheimer's - Apr 02, 2011
- Controlled oxygen therapy slashes death rate among COPD patients - Oct 22, 2010
- Mild asthma might not need to be treated every day: Study - Feb 15, 2011
- Experts review link between diabetes and cancer - Jun 17, 2010
- Long-term use of popular inhalers ups pneumonia risk for COPD patients - Feb 10, 2009
- Exenatide - a physiological option for a pathological disease. - Sep 17, 2009
- Intense diabetes treatment could make sugar levels go 'too low' - Jan 27, 2010
- Poor people are most hard-hit by TB, COPD and tobacco - Nov 06, 2010
- Gene-silencing that could prevent diabetes-related heart failure - Dec 10, 2010
- Benefits of intensive glucose treatment must be weighed against risks - Jun 30, 2010
Tags: accurate estimation, chronic obstructive pulmonary disorder, cohort, copd, corticosteriods, deterioration, diabetes risk, health insurance, hyperglycemia, inhaled corticosteroids, insulin, jewish general hospital, jewish general hospital montreal, lady davis institute, mcgill university, montreal quebec, randomized trials, relative risk, respiratory diseases, suissa